Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for schizophrenia
IRCT201110281556N30Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pioglitazone in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Dec 2011; status: completed.
02
Drugs
pioglitazone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201110281556N30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201110281556N30.